Researchgate profileJulie HENRIQUES is a research engineer in biostatistics. She passed in 2010 a master’s degree in statistical modeling at the University of Franche-Comté. During the master’s degree’s internship in the biostatistics service of the Hospices Civils of Lyon, she realized a study on the correction of survival estimates in the context of loss to follow-up in HIV cohort . She worked as independent statistician for 5 years and participated to projects in many area such as financial times series, reservoir computing or EEG signal processing.
In 2015, she joined the Methodology and quality of life unit in Oncology (UMQVC) at the University hospital of Besancon.
Latest publications
AbstractAim: Adjuvant clinical trials in early human epidermal growth factor receptor 2 (HER2)-positive breast cancer...
Posted by : Dr. Sophie PAGET-BAILLY, Mme. Julie HENRIQUES
Journal name : European Journal of Cancer
AbstractBackground: The intensive care unit is increasingly recognized as a stressful environment for healthcare...
Posted by : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY
Journal name : Ann Intensive Care .
AbstractPurpose: In patients with resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma, surgery plus...
Posted by : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Journal name : Journal of Clinical Oncology
AbstractPatients and methods: A post hoc analysis of all pathologic reports from patients with stage III CC...
Posted by : Mme. Julie HENRIQUES, Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : J Clin Oncol
01
2020, February
AbstractBackground: The use of absorbable meshes during contaminated or infected incisional hernia (IH) repair is...
Posted by : Mme. Julie HENRIQUES
Journal name : J Gastrointest Surg
AbstractBackground: Genome-wide association studies (GWAS) have to date identified 94 genetic variants (single...
Posted by : Dr. Sophie PAGET-BAILLY, Mme. Julie HENRIQUES
Journal name : Breast Cancer Research
AbstractImportance: In the pivotal Bevacizumab-Avastin Adjuvant (AVANT) trial, patients with high-risk stage II...
Posted by : Mme. Julie HENRIQUES
Journal name : JAMA Netw Open .
AbstractBackground: We evaluated the value of pre-treatment positron-emission tomography-computed tomography...
Posted by : Mme. Julie HENRIQUES, Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : Cancers (Basel)
AbstractKeywords: Adjuvant; Chemotherapy; Colon cancer; Guidelines; Randomised controlled trials; Time-to-event...
Posted by : Mme. Julie HENRIQUES, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Journal name : Eur J Cancer
AbstractObjective: To evaluate the effects of switching from prednisone (P) to dexamethasone (D) at asymptomatic...
Posted by : Mme. Julie HENRIQUES, Pr. Franck BONNETAIN
Journal name : BJU Int